P
334970
vs
K
KOSPI 200
Over the past 12 months, Prestige Biologics Co Ltd has underperformed KOSPI 200, delivering a return of -37% compared to the KOSPI 200's +114% growth.
Stocks Performance
334970 vs KOSPI 200
Performance Gap
334970 vs KOSPI 200
Performance By Year
334970 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Prestige Biologics Co Ltd
Glance View
Prestige Biologics Co., Ltd. engages in research, development, and supplying of pharmaceutical products. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 199 full-time employees. The company went IPO on 2021-03-11. The firm mainly engages in the contract manufacturing service business that produces and supplies biopharmaceuticals; and contract development service business that provides development services including cell culture process and purification process.